Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients

被引:26
|
作者
Darvish, Hossein [1 ]
Movafagh, Abolfazl [1 ]
Omrani, Mir Davood [1 ]
Firouzabadi, Saghar Ghasemi [2 ]
Azargashb, Eznollah [3 ]
Jamshidi, Javad [4 ]
Khaligh, Ali [5 ]
Haghnejad, Leyla [1 ]
Naeini, Nilofar Safavi [1 ]
Talebi, Atefeh [6 ]
Heidari-Rostami, Hamid Reza [1 ]
Noorollahi-Moghaddam, Hamid [7 ]
Karkheiran, Siamak [8 ]
Shahidi, Gholam-Ali [8 ]
Paknejad, Seyed Mohammad Hassan [9 ]
Ashrafian, Hossein [10 ]
Abdi, Siamak [7 ]
Kayyal, Matin [11 ]
Akbari, Mojdeh [1 ]
Pedram, Negar [12 ]
Emamalizadeh, Babak [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Fac Med, Dept Med Genet, Tehran, Iran
[2] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Biostat, Tehran, Iran
[4] Fasa Univ Med Sci, Dept Biochem, Fasa, Iran
[5] Sabzevar Univ Med Sci, Sabzevar, Iran
[6] Shahid Beheshti Univ Med Sci, Sch Paramed Sci, Dept Biostat, Tehran, Iran
[7] Univ Tehran Med Sci, Shariati Hosp, Tehran, Iran
[8] Univ Tehran Med Sci, Hazrat Rassol Hosp, Movement Disorders Clin, Tehran, Iran
[9] Shefa Neurosci Ctr, Tehran, Iran
[10] Ghaem Hosp, Karaj, Iran
[11] Islamic Azad Univ, Tehran Med Branch, Dept Biol, Tehran, Iran
[12] Tabriz Univ Med Sci, Dept Med Genet, Fac Med, Tabriz, Iran
关键词
Parkinson's disease; MLPA; Exon dosage; Copy number changes; ONSET; DOSAGE;
D O I
10.1016/j.neulet.2013.07.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after Alzheimer's disease. Genomic rearrangements are common mutations reported in PD patients. In this study, we investigated the prevalence of genomic rearrangements in a total of 232 Iranian PD patients, out of which 102 were sporadic early-onset (age-at-onset <= 45 years) and 51 had a family history. We used multiplex ligation-dependent probe amplification (MLPA) method to detect exon dosage changes. Two new improved probe kits, SALSA P051 and P052, were used and altogether alpha-synuclein, parkin, UCHL1, PINK1, DJ-1, LRRK2, GCH1, ATP13A2, CAV1, CAV2, LPA and TNFRSF9 genes were analyzed. Exon or whole-gene rearrangements were identified in 14(13.7%) sporadic early-onset PD patients in parkin, alpha-synuclein and PINK1. Of familial PD patients 46 cases from 18 families (35.3%) showed exon or whole-gene rearrangements in parkin, alpha-synuclein, PINK1, DJ-1, and ATP13A2 genes. All changes were verified by quantitative PCR (qPCR). Novel mutations and unusual clinical features are reported in this study. Mutations in parkin were the predominant genetic cause in both early-onset and familial PD groups. Also the mutations observed in family PD group are more in number and diversity than the sporadic early-onset PD group. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [1] Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson's Disease
    Ortega-Vazquez, Alberto
    Sanchez-Badajos, Salvador
    Ramirez-Garcia, Miguel Angel
    Alvarez-Luquin, Diana
    Lopez-Lopez, Marisol
    Adalid-Peralta, Laura Virginia
    Monroy-Jaramillo, Nancy
    [J]. GENES, 2023, 14 (10)
  • [2] Copy number variation in Parkinson's disease
    Mathias Toft
    Owen A Ross
    [J]. Genome Medicine, 2
  • [3] Copy number variation in Parkinson's disease
    Toft, Mathias
    Ross, Owen A.
    [J]. GENOME MEDICINE, 2010, 2
  • [4] Assessment of frequencies of simple mutations and copy number variations in five PD genes in Belgian Parkinson's disease patients
    Nuytemans, K.
    Meeus, B.
    Crosiers, D.
    Brouwers, N.
    Pals, P.
    Engelborghs, S.
    Pickut, B.
    Bogaerts, V.
    Corsmit, E.
    Van Den Broeck, M.
    Cras, P.
    De Deyn, P-P
    Van Broeckhoven, C.
    Theuns, J.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S147 - S147
  • [5] What are the factors associated with depression in Parkinson's disease in Iranian patients?
    Mowla, A.
    Mowla, A.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S459 - S460
  • [6] Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson's disease
    Jo, S.
    Oh, J. H.
    Lee, S.
    Lee, J.
    Sung, C. O.
    Chung, S. J.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S478 - S478
  • [7] Detection of copy number variations for two dosage sensitive genes (PARK2 and SNCA) in Parkinson's disease (PD) patients using new NanoString® technology
    Nuytemans, K.
    Bademci, G.
    Wang, L.
    Zuchner, S.
    Nahab, F.
    Singer, C.
    Scott, W.
    Guettouche, T.
    Vance, J. M.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S314 - S315
  • [8] Analysis of HeterozygousPRKNVariants and Copy-Number Variations in Parkinson's Disease
    Yu, Eric
    Rudakou, Uladzislau
    Krohn, Lynne
    Mufti, Kheireddin
    Ruskey, Jennifer A.
    Asayesh, Farnaz
    Estiar, Mehrdad A.
    Spiegelman, Dan
    Surface, Matthew
    Fahn, Stanley
    Waters, Cheryl H.
    Greenbaum, Lior
    Espay, Alberto J.
    Dauvilliers, Yves
    Dupre, Nicolas
    Rouleau, Guy A.
    Hassin-Baer, Sharon
    Fon, Edward A.
    Alcalay, Roy N.
    Gan-Or, Ziv
    [J]. MOVEMENT DISORDERS, 2021, 36 (01) : 178 - 187
  • [9] Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
    Pyle, Angela
    Anugrha, Haidyan
    Kurzawa-Akanbi, Marzena
    Yarnall, Alison
    Burn, David
    Hudson, Gavin
    [J]. NEUROBIOLOGY OF AGING, 2016, 38 : 216.e7 - 216.e10
  • [10] ANALYSIS OF COPY NUMBER VARIANTS IN FAMILIAL AND SPORADIC PARKINSON'S DISEASE
    Joseph, Theresita
    Hehir, Jason
    Tan, Manuela
    Zhang, Wei
    Houlden, Henry
    Lubbe, Steven
    Morris, Huw
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A59 - A60